Matches in SemOpenAlex for { <https://semopenalex.org/work/W2990190811> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2990190811 endingPage "57" @default.
- W2990190811 startingPage "52" @default.
- W2990190811 abstract "Aesthetic dermatologic applications of botulinum neurotoxin (BoNT), including treatment of glabellar lines, horizontal forehead lines, and crow’s feet, were the most common non-surgical cosmetic procedures in the US in 2017, with high levels of subject satisfaction. Since the first BoNT type A (BoNT-A) formulation was approved in 1989, the number of formulations available on the world’s commercial markets has increased and new approvals are expected. BoNT is produced by Clostridium botulinum in nature as part of a large protein complex. However, the unnecessary clostridial proteins, which dissociate from BoNT under physiological conditions with a half-life of <1 minute, have no role in clinical applications. Data demonstrate that BoNT administration can elicit an immunological response, leading to production of neutralizing antibodies that can be associated with reduced efficacy or treatment non-response. As repeat treatments are required to maintain efficacy, clinicians should be aware of the possibility of antibody development and choose a BoNT with the lowest risk of immunogenicity. IncobotulinumtoxinA is manufactured using advanced technology to precisely isolate the pure BoNT without unnecessary clostridial proteins, and with low immunogenicity and high specific activity. In incobotulinumtoxinA clinical studies, no previously BoNT-naïve subjects developed neutralizing antibodies, and there was no secondary non-response to incobotulinumtoxinA treatment. Here we review the role of unnecessary clostridial proteins in BoNT-A and discuss the unique incobotulinumtoxinA manufacturing and purification process with a focus on the implications for use in aesthetic medicine. J Drugs Dermatol. 2019;18(1):52-57." @default.
- W2990190811 created "2019-12-05" @default.
- W2990190811 creator A5006883686 @default.
- W2990190811 creator A5025494704 @default.
- W2990190811 creator A5080986299 @default.
- W2990190811 creator A5088634174 @default.
- W2990190811 creator A5090840400 @default.
- W2990190811 date "2019-01-01" @default.
- W2990190811 modified "2023-10-03" @default.
- W2990190811 title "IncobotulinumtoxinA: A Highly Purified and Precisely Manufactured Botulinum Neurotoxin Type A" @default.
- W2990190811 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30681794" @default.
- W2990190811 hasPublicationYear "2019" @default.
- W2990190811 type Work @default.
- W2990190811 sameAs 2990190811 @default.
- W2990190811 citedByCount "11" @default.
- W2990190811 countsByYear W29901908112020 @default.
- W2990190811 countsByYear W29901908112021 @default.
- W2990190811 countsByYear W29901908112022 @default.
- W2990190811 countsByYear W29901908112023 @default.
- W2990190811 crossrefType "journal-article" @default.
- W2990190811 hasAuthorship W2990190811A5006883686 @default.
- W2990190811 hasAuthorship W2990190811A5025494704 @default.
- W2990190811 hasAuthorship W2990190811A5080986299 @default.
- W2990190811 hasAuthorship W2990190811A5088634174 @default.
- W2990190811 hasAuthorship W2990190811A5090840400 @default.
- W2990190811 hasConcept C141071460 @default.
- W2990190811 hasConcept C159654299 @default.
- W2990190811 hasConcept C16005928 @default.
- W2990190811 hasConcept C203014093 @default.
- W2990190811 hasConcept C2777010668 @default.
- W2990190811 hasConcept C2777367657 @default.
- W2990190811 hasConcept C2777478456 @default.
- W2990190811 hasConcept C2779261636 @default.
- W2990190811 hasConcept C2780446394 @default.
- W2990190811 hasConcept C2780868878 @default.
- W2990190811 hasConcept C2994342964 @default.
- W2990190811 hasConcept C71924100 @default.
- W2990190811 hasConcept C86803240 @default.
- W2990190811 hasConcept C89423630 @default.
- W2990190811 hasConceptScore W2990190811C141071460 @default.
- W2990190811 hasConceptScore W2990190811C159654299 @default.
- W2990190811 hasConceptScore W2990190811C16005928 @default.
- W2990190811 hasConceptScore W2990190811C203014093 @default.
- W2990190811 hasConceptScore W2990190811C2777010668 @default.
- W2990190811 hasConceptScore W2990190811C2777367657 @default.
- W2990190811 hasConceptScore W2990190811C2777478456 @default.
- W2990190811 hasConceptScore W2990190811C2779261636 @default.
- W2990190811 hasConceptScore W2990190811C2780446394 @default.
- W2990190811 hasConceptScore W2990190811C2780868878 @default.
- W2990190811 hasConceptScore W2990190811C2994342964 @default.
- W2990190811 hasConceptScore W2990190811C71924100 @default.
- W2990190811 hasConceptScore W2990190811C86803240 @default.
- W2990190811 hasConceptScore W2990190811C89423630 @default.
- W2990190811 hasIssue "1" @default.
- W2990190811 hasLocation W29901908111 @default.
- W2990190811 hasOpenAccess W2990190811 @default.
- W2990190811 hasPrimaryLocation W29901908111 @default.
- W2990190811 hasRelatedWork W124942673 @default.
- W2990190811 hasRelatedWork W1975308015 @default.
- W2990190811 hasRelatedWork W1976647322 @default.
- W2990190811 hasRelatedWork W1995748614 @default.
- W2990190811 hasRelatedWork W2107750870 @default.
- W2990190811 hasRelatedWork W2166825283 @default.
- W2990190811 hasRelatedWork W2348101972 @default.
- W2990190811 hasRelatedWork W2981986409 @default.
- W2990190811 hasRelatedWork W2990190811 @default.
- W2990190811 hasRelatedWork W4206197624 @default.
- W2990190811 hasVolume "18" @default.
- W2990190811 isParatext "false" @default.
- W2990190811 isRetracted "false" @default.
- W2990190811 magId "2990190811" @default.
- W2990190811 workType "article" @default.